Cancer vaccines have emerged as a promising therapeutic approach in immuno-oncology, harnessing the body's immune system to target and eliminate cancer cells. Cancer vaccines can be broadly categorized into two types: preventive (prophylactic) vaccines and therapeutic (treatment) vaccines. Preventive vaccines aim to prevent certain cancer types by targeting infectious agents known to cause cancer, such as the human papillomavirus (HPV) vaccine to prevent cervical cancer. Therapeutic vaccines ... Read more

The global Immuno-oncology Drugs Market is estimated to be valued at US$ 17,394.2 million in 2023 and is expected to exhibit a CAGR of 16.8% over the forecast period 2023-2030.

A) Market Overview:

The Immuno-oncology Drugs Market includes various drugs and therapies that utilize the body's immune system to fight cancer. These drugs work by enhancing the immune response against cancer cells, thereby improving the survival rates and quality of life for ... Read more